301 filings
Page 9 of 16
8-K
n662f17nkqm2m7nv
4 Dec 15
Unregistered Sales of Equity Securities
12:00am
8-K
zzavwurf3 crewoetx
9 Oct 15
Other Events
12:00am
8-K
7sintkkcsw04
28 Jul 15
Oragenics Reports PositiveIn Vivo Antibiotic Efficacy Data in Critical Animal Study
12:00am
8-K
oxn3b5pm7yhss801 fw
21 Jul 15
Oragenics Shareholders Re-elect Existing Board of Directors; Approve and Ratify other Proposals
12:00am
8-K
2kn0v9v39i 6xrt0x
11 Jun 15
Intrexon and Oragenics Expand Collaboration to Pursue Development
12:00am
8-K
el17s xp9w8k
18 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
hmh4q 9s3ki0c3
25 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
ev1uyo99c3zx36s1tk
22 Dec 14
Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business
12:00am
8-K
sw94jc4vbq
10 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
bsdwz
31 Oct 14
Oragenics, Inc. Announces Change in Management and Board of Directors
12:00am
8-K
c9mrw
3 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
zgkj1hd m7ybjr7r
16 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
99yza78 5yp06czmg
16 Jan 14
Certain statements made in this presentation include forward-looking actions that
12:00am
8-K
kufhmw
20 Dec 13
Unregistered Sales of Equity Securities
12:00am
8-K
mizs3h sc
2 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
xtn9vsxj1iuxrtyz
20 Nov 13
Oragenics Announces Completion of Public Offering of Common Stock
12:00am
8-K
wq1sre8d5rqbyxf1w9p4
15 Nov 13
Oragenics Prices Public Offering of Common Stock
12:00am
8-K
8rsfl9vqs
15 Nov 13
Oragenics Announces Proposed Public Offering of Common Stock
12:00am
8-K
nkct 8z3xmef5y
31 Oct 13
Oragenics Announces Breakthrough Antibiotic Analog Generation in Intrexon Collaboration
12:00am
8-K
lzc567k8kwvpnmynh4
22 Oct 13
Departure of Directors or Certain Officers
12:00am